| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |